Lumos Pharma (LUMO) Insider Trading & Ownership → AI “wealth window” is closing June 25th (From Paradigm Press) (Ad) Free LUMO Stock Alerts $3.02 +0.02 (+0.67%) (As of 05/7/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Lumos Pharma (NASDAQ:LUMO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage25.40%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$18,396.39 Get LUMO Insider Trade Alerts Want to know when executives and insiders are buying or selling Lumos Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address LUMO Insider Buying and Selling by Quarter Ad Paradigm PressAI “wealth window” is closing June 25thToday, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.I put together this personal video [HERE]… Lumos Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/3/2024John C MckewInsiderSell2,214$2.77$6,132.78 2/6/2024John C MckewInsiderSell438$3.03$1,327.14 8/2/2023John C MckewInsiderSell3,407$3.21$10,936.47 (Data available from 1/1/2013 forward) LUMO Insider Trading Activity - Frequently Asked Questions Who is on Lumos Pharma's Insider Roster? The list of insiders at Lumos Pharma includes John C Mckew, Kevin M Lalande, Richard J Hawkins, and Thomas A Raffin. Learn more on insiders at LUMO. What percentage of Lumos Pharma stock is owned by insiders? 25.40% of Lumos Pharma stock is owned by insiders. Learn more on LUMO's insider holdings. Which Lumos Pharma insiders have been buying company stock? The following insiders have purchased LUMO shares in the last 24 months: Richard J Hawkins ($26,081.81), and Thomas A Raffin ($9,729.00). How much insider buying is happening at Lumos Pharma? Insiders have purchased a total of 4,113 LUMO shares in the last 24 months for a total of $35,810.81 bought. Which Lumos Pharma insiders have been selling company stock? The following insider sold LUMO shares in the last 24 months: John C Mckew ($54,554.72). How much insider selling is happening at Lumos Pharma? Insiders have sold a total of 11,849 Lumos Pharma shares in the last 24 months for a total of $54,554.72 sold. More Insider Trading Tools from MarketBeat Related Companies: BIOR Insider Ownership CPIX Insider Ownership ONCT Insider Ownership BFRG Insider Ownership LPCN Insider Ownership BNTC Insider Ownership TXMD Insider Ownership FLGC Insider Ownership ITRM Insider Ownership RNXT Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year This page (NASDAQ:LUMO) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Department of Defense Has a New Drone ContractorThe Tomorrow Investor[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsAI “wealth window” is closing June 25thParadigm PressStock-Picking AI Predicts #1 Stock of 2024AltimetryElon Musk Secret Crypto Plot ExposedCrypto 101 MediaThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyThe AI Stock that’s Disrupting Every IndustryStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lumos Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
